INVO Bioscience Agrees To Acquire NAYA Biosciences In An All-Stock Transaction
Portfolio Pulse from Benzinga Newsdesk
INVO Bioscience has agreed to acquire NAYA Biosciences in an all-stock transaction. NAYA Biosciences' shareholders will receive 7.3333 shares of INVO for each share of NAYA Biosciences, totaling approximately 18,150,000 shares of INVO. The combined company will operate under the name 'NAYA Biosciences'.
October 23, 2023 | 11:36 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
INVO Bioscience's acquisition of NAYA Biosciences could potentially dilute the value of INVO's shares due to the issuance of approximately 18,150,000 new shares.
The all-stock acquisition of NAYA Biosciences by INVO Bioscience involves the issuance of approximately 18,150,000 new shares of INVO. This could potentially dilute the value of existing shares of INVO, leading to a negative short-term impact on the stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100